Zhu Y - Search Results

1

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.

Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W. Li F, et al. Among authors: zhu y. Drug Resist Updat. 2023 May;68:100938. doi: 10.1016/j.drup.2023.100938. Epub 2023 Feb 9. Drug Resist Updat. 2023. PMID: 36774746 Review.

2

Effect of Shengmai Yin on Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Radioresistant Cells.

Wang ZT, Peng Y, Lou DD, Zeng SY, Zhu YC, Li AW, Lyu Y, Zhu DQ, Fan Q. Wang ZT, et al. Among authors: zhu dq, zhu yc. Chin J Integr Med. 2023 Aug;29(8):691-698. doi: 10.1007/s11655-022-3689-2. Epub 2022 Dec 7. Chin J Integr Med. 2023. PMID: 36477450 Free PMC article.

3

Regulation of ncRNAs involved with ferroptosis in various cancers.

Hu C, Zeng X, Zhu Y, Huang Z, Liu J, Ji D, Zheng Z, Wang Q, Tan W. Hu C, et al. Among authors: zhu y. Front Genet. 2023 Mar 29;14:1136240. doi: 10.3389/fgene.2023.1136240. eCollection 2023. Front Genet. 2023. PMID: 37065473 Free PMC article. Review.

4

CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.

Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q, Liu X, Zeng S, Xiao Y, Hu C, Pang S, Wang T, Xu B, Peng P, Li F, Tan W. Zheng Z, et al. Among authors: zhu y. Mol Cancer. 2024 Jan 6;23(1):4. doi: 10.1186/s12943-023-01912-w. Mol Cancer. 2024. PMID: 38184608 Free PMC article.

5

Development and experimental validation of an M2 macrophage and platelet-associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer.

Muhuitijiang B, Zhou J, Zhou R, Zhang Z, Yan G, Zheng Z, Zeng X, Zhu Y, Wu H, Gao R, Zhu T, Shi X, Tan W. Muhuitijiang B, et al. Among authors: zhu t, zhu y. Cancer Sci. 2024 May;115(5):1417-1432. doi: 10.1111/cas.16113. Epub 2024 Feb 29. Cancer Sci. 2024. PMID: 38422408 Free PMC article.

6

Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.

Zhou J, Zhou R, Zhu Y, Deng S, Muhuitijiang B, Li C, Shi X, Zhang L, Tan W. Zhou J, et al. Among authors: zhu y. J Exp Clin Cancer Res. 2024 Apr 2;43(1):101. doi: 10.1186/s13046-024-03017-8. J Exp Clin Cancer Res. 2024. PMID: 38566204 Free PMC article.

7

EGR1 Promotes Ovarian Hyperstimulation Syndrome Through Upregulation of SOX9 Expression.

Wang H, Chen W, Huang Y, Sun Y, Liu Y, Zhu Y, Lu Z. Wang H, et al. Among authors: zhu y. Cell Transplant. 2023 Jan-Dec;32:9636897231193073. doi: 10.1177/09636897231193073. Cell Transplant. 2023. PMID: 37737125 Free PMC article.

8

Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy.

Ming ZH, Zhang YQ, Song L, Chen M, Lin LL, He YY, Liu WL, Zhu YY, Zhang Y, Zhang GJ. Ming ZH, et al. Among authors: zhu yy. Adv Sci (Weinh). 2024 May 22:e2309992. doi: 10.1002/advs.202309992. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38774946

9

MultiBench: Multiscale Benchmarks for Multimodal Representation Learning.

Liang PP, Lyu Y, Fan X, Wu Z, Cheng Y, Wu J, Chen L, Wu P, Lee MA, Zhu Y, Salakhutdinov R, Morency LP. Liang PP, et al. Among authors: zhu y. Adv Neural Inf Process Syst. 2021 Dec;2021(DB1):1-20. Adv Neural Inf Process Syst. 2021. PMID: 38774625 Free PMC article.

10

Oral immunotherapy with enteric-coated capsules for allergic rhinitis caused by house dust mites.

Zhang HZ, Xie W, Zhou WC, Chen J, Wang Y, Zhu YY, Wen TH, Cheng L. Zhang HZ, et al. Among authors: zhu yy. Front Allergy. 2024 May 7;5:1345929. doi: 10.3389/falgy.2024.1345929. eCollection 2024. Front Allergy. 2024. PMID: 38774588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50,424 results

Search Page